Anaplastic Large Cell Lymphoma, ALK-Negative

13 clinical trials · Condition

Record	Firm	Date
CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study (NCT04480788)	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	2020-11-24
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451)	BeiGene	2018-04-13
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625)	National Cancer Institute (NCI)	2017-09-27
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma (NCT03113500)	City of Hope Medical Center	2017-05-25
Risk Stratification of Nodal PTCL (NCT03040206)	Chonbuk National University Hospital	2017-01-01
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma (NCT02561273)	University of Nebraska	2015-09-28
CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study (NCT01719835)	Royal Marsden NHS Foundation Trust	2012-03-01
RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas (NCT01198665)	Samsung Medical Center	2010-07-01
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma (NCT01035463)	University of Nebraska	2009-11-12

Every clearance here is in the API, with alerts when new ones post.